When to use frovatriptan in migraine? A reply

Journal of Headache and Pain

Volumn 12, Issue 3, 2011, Pages 395-396

  Fierro, Brigida ^a   Omboni, Stefano ^b   Bartolini, Marco ^c   Savi, Lidia ^d   Pinessi, Lorenzo ^d  

^a UNIVERSITY OF PALERMO   (Italy)

^b ITALIAN INSTITUTE OF TELEMEDICINE   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; FROVATRIPTAN; PLACEBO; RIZATRIPTAN; SUMATRIPTAN;

ANALGESIA; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; LETTER; MIGRAINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

EID: 79958101334     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-011-0347-z     Document Type: Letter

References (10)

1. Tfelt-Hansen PC (2011) When to use frovatriptan in migraine? J Headache Pain. doi: 10.1007/s10194-011-0341-5
2. L Savi S Omboni C Lisotto G Zanchin MD Ferrari D Zava, et al. 2011 A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine J Headache Pain 12 219 226 20686810 10.1007/s10194-010-0243-y 1:CAS:528:DC%2BC3MXksVCgu70%3D
3. Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B et al (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain. doi: 10.1007/s10194-011-0325-5
4. Saxena PR, Tfelt-Hansen P (2006) Triptans, 5HT1B/1D agonists in the acute treatment of migraine. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 469-503
5. P Tfelt-Hansen 2008 Frovatriptan and data publication Headache 48 1382 1383 19006553 10.1111/j.1526-4610.2008.01064.x (Pubitemid 351467624)
6. J Hutchinson V Pfaffenrath G Geraud 2008 A randomized, placebo-controlled, parallel-group trial of frovatriptan and sumatriptan for a single acute migraine attack Eur J Neurol 14 Suppl 1 144
7. R Ryan G Géraud J Goldstein R Cady C Keywood 2002 Clinical efficacy of frovatriptan: placebo-controlled studies Headache 42 Suppl 2 S84 S92 12028324 10.1046/j.1526-4610.42.s2.6.x
8. EA Balbisi 2004 Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine Int J Clin Pract 58 695 705 15311727 10.1111/j.1368-5031.2004.00218.x 1:CAS:528:DC%2BD2cXnsVChu7g%3D (Pubitemid 39144585)
9. G Géraud C Keywood JM Senard 2003 Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans Headache 43 376 388 12656709 10.1046/j.1526-4610.2003.03073.x (Pubitemid 36417768)
10. G Géraud EL Spierings C Keywood 2002 Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan Headache 42 Suppl 2 S93 S99 12028325 10.1046/j.1526-4610.42.s2.7.x